Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 1.53b
Percent of heart failure patients with left ventricular systolic dysfunction prescribed ACE inhibitor or angiotensin receptor blocker at discharge, all payers, by State, 2005
State Percent Standard error
United States 82.9 0.4
Alabama 83.1 0.5
Alaska 89.5 1.7
Arizona 81.6 0.6
Arkansas 77.1 0.6
California 83.3 0.2
Colorado 84.9 0.8
Connecticut 82.5 0.6
Delaware 75.7 1.4
District of Columbia 81.9 1.2
Florida 79.9 0.3
Georgia 80.4 0.4
Hawaii 80.8 1.1
Idaho 83.1 1.6
Illinois 82.4 0.3
Indiana 81.1 0.4
Iowa 88.2 0.6
Kansas 81.7 0.8
Kentucky 77.7 0.5
Louisiana 81.0 0.4
Maine 83.7 1.1
Maryland 83.8 0.4
Massachusetts 84.7 0.4
Michigan 87.0 0.3
Minnesota 83.4 0.6
Mississippi 82.0 0.6
Missouri 84.3 0.4
Montana 87.2 1.3
Nebraska 84.3 0.8
Nevada 81.8 0.9
New Hampshire 87.3 1.1
New Jersey 87.9 0.3
New Mexico 79.2 1.2
New York 82.9 0.3
North Carolina 83.7 0.4
North Dakota 86.8 1.4
Ohio 84.4 0.3
Oklahoma 85.5 0.5
Oregon 83.2 0.8
Pennsylvania 81.1 0.3
Puerto Rico 80.8 0.8
Rhode Island 85.9 1.1
South Carolina 85.7 0.5
South Dakota 84.9 1.5
Tennessee 80.1 0.4
Texas 81.5 0.3
Utah 84.8 1.2
Vermont 79.5 2.0
Virginia 80.2 0.4
Washington 84.8 0.6
West Virginia 81.6 0.7
Wisconsin 83.9 0.5
Wyoming 79.0 2.7

Key: ACE: angiotensin converting enzyme.

Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.

 

AHRQ Advancing Excellence in Health Care